Deciding on Preventative Surgery Options

Deciding whether to undergo preventative surgery is one of the most personal and complex parts of managing a PALB2 diagnosis. Unlike some other genetic conditions where surgery is often a standard recommendation, preventative surgery for PALB2 is a shared decision. This means there is no single “right” answer; the best choice depends on your personal risk, your family history, and your own values regarding quality of life ^[1][2].

Risk-Reducing Mastectomy (RRM)

A risk-reducing mastectomy—the surgical removal of breast tissue to prevent cancer—is an option you may discuss with your care team. It is not considered a mandatory “standard of care” for every PALB2 carrier ^[1].

• The Benefit: In high-risk groups, this surgery can reduce the risk of developing breast cancer by approximately 90% ^[3].
• The Uncertainty: While the reduction in cancer incidence is clear, we do not yet have definitive evidence that this surgery improves long-term survival for PALB2 carriers compared to those who choose intensive screening (MRIs and mammograms) ^[1][4].
• Individualizing the Decision: Your doctor may use a tool like CanRisk (also known as BOADICEA) to calculate your absolute risk. This model considers your age, your specific PALB2 variant, and your family history to help you visualize your personal benefit from surgery ^[5][6].
• The Contralateral Risk: If you have already had breast cancer in one breast, your risk of developing it in the other (contralateral breast cancer) may be higher if your first tumor was ER-negative (estrogen receptor negative). In one study, premenopausal PALB2 carriers with ER-negative disease had a 35% chance of a second cancer within 10 years ^[7].

The Trade-offs: Surgery is irreversible and carries a “surgical burden.” Complications occur in about 13% of cases, and many patients (nearly 40% in some studies) may require additional follow-up surgeries over the next five years ^[8]. You should also consider the permanent loss of breast sensation and the emotional impact of reconstruction ^[6].

Risk-Reducing Salpingo-Oophorectomy (RRSO)

Because the lifetime risk of ovarian cancer for PALB2 carriers is approximately 5%—significantly lower than the risk associated with BRCA1 or BRCA2—the timing and necessity of removing the fallopian tubes and ovaries (RRSO) are viewed differently ^[5].

• Age Recommendations: Many expert recommendations advise discussing RRSO around ages 45 to 50 for PALB2 carriers ^[1].
• The Exception: Surgery might be considered earlier (usually after childbearing is complete) if you have a strong family history of ovarian cancer, high ovarian-cancer risk, or specific reproductive plans that a genetic counselor identifies ^[9].
• Residual Risk: It is important to note that while RRSO substantially reduces risk, it does not eliminate pelvic or primary-peritoneal cancer risk entirely ^[10].
• Individual Choice: Because the risk is relatively low, many women choose to delay this surgery until they reach natural menopause, avoiding the health complications of surgical menopause ^[1][11].

The Consequences of Premature Menopause

If you choose to have your ovaries removed before you reach natural menopause, your body will enter surgical menopause abruptly. This is not the same as natural menopause, which happens gradually over years. The sudden loss of hormones can have significant effects on your long-term health:

• Bone Health: Estrogen protects your bones. Without it, you face a measurable loss in bone mineral density (BMD). One study found a spine density loss of nearly 6% within three years of surgery ^[12]. This increases your risk of osteoporosis and bone fractures later in life ^[13].
• Sexual Health: Surgical menopause often leads to persistent changes in sexual function, including decreased desire, difficulty with lubrication, and physical discomfort or pain during intercourse ^[14]. Over 15 years after surgery, women report significantly more vaginal dryness than those who went through menopause naturally ^[15].
• Quality of Life: Vasomotor symptoms, such as hot flushes, can be intense. In studies of high-risk carriers, hot flush prevalence jumped from 6% before surgery to nearly 60% within two years ^[16]. Sleep and mood can also be affected ^[17].
• Heart Health: While the evidence is still being studied, some research suggests a potential increase in cardiovascular risk when ovaries are removed at a young age, though these findings are mixed ^[18][19].

Making the Decision That Is Right for You

There is no “one size fits all” path for PALB2 carriers. Some women feel that the high risk of breast cancer makes surgery the most empowering choice, while others prefer the high-tech safety net of annual MRIs to avoid the physical and hormonal changes of surgery ^[6][11].

If you do choose surgery before age 50, your doctor may discuss Menopausal Hormone Therapy (MHT). While data for PALB2 specifically is limited, studies extrapolated from BRCA carriers suggest that short-term hormone therapy to manage symptoms until the natural age of menopause (around age 51) may be safe and does not appear to cancel out the benefits of the surgery ^[19][20]. However, if you have a personal history of breast cancer—especially hormone-receptor-positive disease—systemic therapy may be inappropriate and requires careful coordination with your oncologist ^[20]. Your care team—including your surgeon, oncologist, and a menopause specialist—should help you weigh these complex factors against your personal life goals ^[6].